Advertisement

Ruxolitinib Treatment in an Infant with JAK2+ Polycythaemia Vera-Associated Budd-Chiari Syndrome

Budd-Chiari syndrome is caused by hepatic venous outflow obstruction commonly seen with myeloproliferative neoplasms. Treatment with modified ruxolitinib has been effective for almost 20 months with a good response and no side effects.

 BMJ Case Rep